🔎 Trials Near Me

Home › Neuroblastoma › Pennsylvania › Philadelphia

Neuroblastoma clinical trials in Philadelphia, PA

9 studies for Neuroblastoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

RecruitingPhase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi away
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · All sexes · Updated Sep 17, 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

RecruitingPhase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi away
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

RecruitingPhase 1/2
  • Children's Hospital of Philedephia, Philadelphia
Ages 2 to 21 · All sexes · Updated Aug 11, 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

RecruitingPhase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 1 to 30 · All sexes · Updated Jul 22, 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

RecruitingPhase 2
  • Children's Hospital of Philadelphia, Philadelphia
Ages 1 to 31 · All sexes · Updated Jul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

RecruitingObservational study
  • Children's Hospital of Philadelphia, Philadelphia
31 Days – 99 Years · All sexes · Updated Mar 23, 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Recruiting
  • Children's Hospital of Philadelphia, Philadelphia
Up to age 17 · All sexes · Updated Feb 10, 2026 · NCT06831552

About Neuroblastoma

Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.

More about Neuroblastoma on MedlinePlus

Neuroblastoma trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.